Kidney Cancer

Hormone Analog is Promising New Treatment

Published in Cancer Weekly, June 27th, 2000

Reporting in the June 1, 2000, issue of Cancer Research, U.S. Department of Veterans Affairs (VA) scientists and colleagues have identified a promising new treatment for kidney cancer.

Using a laboratory-developed analog of somatostatin, a hypothalamic hormone that inhibits the release of growth hormone, researchers were able to target specific receptors on tumor sites and reverse cancer growth. This potent compound could be the "magic bullet" in the fight against a cancer particularly resistant to therapy.

"This analog is super potent. The targeted chemotherapy inhibited the tumors beautifully," said research leader Andrew V. Schally, a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-06-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry